Continued FDA approval of iptacopan was contingent on 2-year trial data ...

Iptacopan is a complement factor B inhibitor targeting the overactive alternative complement pathway in IgA nephropathy.

Gelatine Sculpt is positioned within the evolving landscape of weight management solutions as a structured, liquid-based ...

EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada ...

BASF Agricultural Solutions will establish more than 50 new global corporate and governance roles in Bucharest in a move to ...

EMPAVELI (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced ...

New research reveals impaired fibre metabolism in celiac disease. Fibre supplementation may support gut microbiota and ...

Weight loss is complex. Traditional metrics like kilograms lost and BMI tell only part of the story. The next era of obesity trials demands evidence that goes underneath the lost kilos, evidence that ...

Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta gr ...

Purina Pro Plan is expanding options with a new lineup built around digestive and immune support. The brand's AdvantEdge ...

Check out the list of the 7 top 60cm kitchen chimneys with auto clean function on Amazon to choose the one that allows proper ...

A common eye-health nutrient, zeaxanthin, may also help the body fight cancer more effectively. Scientists discovered it strengthens T cells and enhances the impact of immunotherapy treatments. Found ...